Victor G Matassa

This inventor holds 17 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Merck Sharpe & Dohme Corp.. Active years: 1994-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor G Matassa. Retrieved from https://idiyas.com/inventor/victor-g-matassa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 315(Granted Patents)

Location History:

Herts, GB (1996)
Furneux Pelham, GB (1994 - 1997)
Hertfordshire, GB (1997)

Company Filing History:

16 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 36

Merck Sharpe & Dohme Corp.

patents

Years Active: 1994-1997

Loading Chart...

Areas of Expertise:

Benzodiazepine Derivatives

Imidazole Derivatives

Triazole Derivatives

Tetrazole Derivatives

Cholecystokinin Antagonists

Gastrin Antagonists

Heteroaromatic Compounds

5-Hydroxytryptamine Agonists

4-Substituted Triazoles

Thienodiazepine Derivatives

Indole Derivatives

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5696110 - Benzodiazepine derivatives and their use as antagonists of (1997-12-09),

2. 5681833 - Benzodiazepine derivatives (1997-10-28),

3. 5618812 - Benzodiazepine derivatives (1997-04-08),

4. 5607957 - Imidazole, triazole and tetrazole derivatives (1997-03-04),

5. 5602163 - Imidazole, triazole and tetrazole derivatives (1997-02-11),

6. 5602162 - Imidazole, triazole and tetrazole derivatives (1997-02-11),

7. 5602125 - Thienodiazepine derivatives as cholecystokinin and gastrin antagonists (1997-02-11),

8. 5597915 - Benzodiazepine derivatives, compositions containing them and their use (1997-01-28),

9. 5567726 - Imidazole, Triazole and tetrazole derivatives (1996-10-22),

10. 5554629 - 4-substituted 1,2,4-triazole derivatives (1996-09-10),

11. 5521175 - Benzodiazepine derivatives (1996-05-28),

12. 5510362 - Imidazole, triazole and tetrazole derivatives (1996-04-23),

13. 5510359 - Heteroaromatic 5-hydroxytryptamine receptor agonists (1996-04-23),

14. 5451588 - Imidazole, triazole and tetrazole derivatives (1995-09-19),

15. 5451582 - Benzodiazepine derivatives, compositions containing them and their use (1995-09-19),

Title: Victor G Matassa: Pioneering Inventor in Pharmacology

Introduction:

Victor G Matassa, a talented inventor in the field of pharmacology, hails from Furneux Pelham, GB. With an impressive portfolio of 17 patents to his name, Matassa has made significant contributions to the development of innovative pharmaceutical compounds.

Latest Patents:

One of his recent patents includes Benzodiazepine derivatives and their use as antagonists of compounds, which are CCK and/or gastrin antagonists. These compounds and compositions have shown considerable potential for therapeutic applications.

Career Highlights:

Matassa has been associated with esteemed organizations such as Merck Sharp & Dohme Corporation, where he has showcased his expertise in pharmaceutical research and development. His work has led to advancements in the field of pharmacology and drug discovery.

Collaborations:

Throughout his career, Matassa has had the privilege of collaborating with industry experts such as Leslie Joseph Street and Raymond Baker. These collaborations have been instrumental in driving forward groundbreaking research and innovations in the pharmaceutical sector.

Conclusion:

In conclusion, Victor G Matassa stands out as a prominent figure in the realm of pharmacological inventions. His dedication to pushing the boundaries of pharmaceutical science has established him as a pioneering inventor, shaping the future of therapeutic interventions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]